Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Outer Bio secures approximately $23M in funding led by Wing Venture Capital and Initialized Capital. The capital will be used to expand lab automation and enhance research teams.

PRIVATEAug 26, 2026•about 3 hours ago

Amount Raised

$23 Million

Round Type

Venture - Series Unknown

CambridgeBiotechnologyArtificial IntelligenceTherapeuticsMachine Learning

Investors

Sv AngelLiquid 2 VenturesThird Kind Venture CapitalLightspeed Venture PartnersHawktailSozo VenturesInitialized CapitalWing Venture Capital

Description

Outer Bio, a Cambridge-based AI biotechnology and dermatology platform, has emerged from stealth after raising approximately $23M. The funding will help the company grow its laboratory automation infrastructure and research teams. Investors include Wing Venture Capital, Initialized Capital, and several others. Outer Bio develops Yuna, a platform maintaining living human skin for research.

Company Information

Company

Outer Bio

Location

Cambridge, Massachusetts, United States

About

Outer Bio is an AI biotechnology and dermatology platform developer based in Cambridge, MA. The company has developed Yuna, an ex vivo human-skin tissue platform that maintains living human skin for extended periods. It applies machine learning to enhance bioactive discovery for biopharma and skincare. Co-founded by CEO Michael Polansky and board member Stefani Germanotta.

Don't miss Outer Bio's next move

Get an email the moment Outer Bio raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Outer Bio's next move

Learn about Strategic plan

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Outer Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.